Blocking p62-dependent SMN degradation ameliorates spinal muscular atrophy disease phenotypes

Natalia Rodríguez‐Muela(German Center for Neurodegenerative Diseases), Lee L. Rubin(Harvard University)
Journal of Clinical Investigation
April 19, 2018
Cited by 40


Related Papers